ACHN - Achillion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5524.48M
Enterprise Value 3233.88M
Trailing P/E N/A
Forward P/E 1-6.13
PEG Ratio (5 yr expected) 1-0.41
Price/Sales (ttm)N/A
Price/Book (mrq)1.62
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.64

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-14.90%
Return on Equity (ttm)-23.55%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -88.45M
Net Income Avi to Common (ttm)-85.24M
Diluted EPS (ttm)-0.6210
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)300.07M
Total Cash Per Share (mrq)2.18
Total Debt (mrq)301k
Total Debt/Equity (mrq)0.09
Current Ratio (mrq)23.59
Book Value Per Share (mrq)2.35

Cash Flow Statement

Operating Cash Flow (ttm)-59.48M
Levered Free Cash Flow (ttm)-31M

Trading Information

Stock Price History

Beta 0.76
52-Week Change 32.64%
S&P500 52-Week Change 312.69%
52 Week High 35.6600
52 Week Low 32.5800
50-Day Moving Average 33.3926
200-Day Moving Average 33.5425

Share Statistics

Avg Vol (3 month) 32.25M
Avg Vol (10 day) 32.21M
Shares Outstanding 5137.89M
Float 115.99M
% Held by Insiders 10.11%
% Held by Institutions 186.84%
Shares Short 38.64M
Short Ratio 35.41
Short % of Float 37.46%
Shares Short (prior month) 38.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A